title: Colostrum from cows immunized with a vaccine associated with bovine neonatal pancytopenia contains allo-antibodies that cross-react with human MHC-I molecules.
abstract: In 2006, a new haemorrhagic syndrome affecting newborn calves, Bovine Neonatal Pancytopenia (BNP), was reported in southern Germany. It is characterized by severe bleeding, destruction of the red bone marrow, and a high case fatality rate. The syndrome is caused by alloreactive, maternal antibodies that are ingested by the calf with colostrum and result from a dam vaccination with one particular vaccine against Bovine-Viral-Diarrhoea-Virus. Because bovine colostrum is increasingly gaining interest as a dietary supplement for human consumption, the current study was initiated to elucidate whether BNP alloantibodies from BNP dams (i.e. animals that gave birth to a BNP-affected calf) cross-react with human cells, which could pose a health hazard for human consumers of colostral products. The present study clearly demonstrates that BNP alloantibodies cross-react with human lymphocytes in vitro. In agreement with previous reports on BNP, the cross-reactive antibodies are specific for MHC-I molecules, and sensitize opsonised human cells for in vitro complement lysis. Cross-reactive antibodies are present in serum and colostrum of individual BNP dams. They can be traced in commercial colostrum powder manufactured from cows immunized with the vaccine associated with BNP, but are absent from commercial powder manufactured from colostrum excluding such vaccinated cows. In humans alloreactive, MHC-I specific antibodies are generally not believed to cause severe symptoms. However, to minimize any theoretical risk for human consumers, manufacturers of bovine colostrum for human consumption should consider using only colostrum from animals that have not been exposed to the vaccine associated with BNP.
authors.affiliation: Division of Veterinary Medicine, Paul-Ehrlich-Institut, Langen, Germany.
authors.forename: Rahel
authors.initials: R
authors.lastname: Kasonta
authors.affiliation: Landwirtschaftskammer Nordrhein-Westfalen, Referat 34 Tiergesundheit, Bonn, Germany.
authors.forename: Mark
authors.initials: M
authors.lastname: Holsteg
authors.affiliation: Division of Veterinary Medicine, Paul-Ehrlich-Institut, Langen, Germany.
authors.forename: Karin
authors.initials: K
authors.lastname: Duchow
authors.affiliation: Fonterra Research and Development Centre, Palmerston North, New Zealand.
authors.forename: James W
authors.initials: JW
authors.lastname: Dekker
authors.affiliation: Division of Veterinary Medicine, Paul-Ehrlich-Institut, Langen, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Cussler
authors.affiliation: Fonterra Research and Development Centre, Palmerston North, New Zealand.
authors.forename: Justin G
authors.initials: JG
authors.lastname: Bendall
authors.affiliation: Division of Veterinary Medicine, Paul-Ehrlich-Institut, Langen, Germany.
authors.forename: Max
authors.initials: M
authors.lastname: Bastian
mesh_terms: D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D001826:Body Fluids / Q000276:immunology; D001853:Bone Marrow / Q000276:immunology; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology*; D002478:Cells, Cultured; D003126:Colostrum / Q000276:immunology*; D003429:Cross Reactions / Q000276:immunology*; D001908:Diarrhea Viruses, Bovine Viral / Q000276:immunology; D005260:Female; D005805:Genes, MHC Class I / Q000276:immunology*; D005858:Germany; D006801:Humans; D007114:Immunization / Q000379:methods; D007518:Isoantibodies / Q000276:immunology*; D007962:Leukocytes / Q000276:immunology; D010198:Pancytopenia / Q000276:immunology* / Q000662:veterinary; D011247:Pregnancy; D014611:Vaccination / Q000379:methods; D014612:Vaccines / Q000276:immunology*
chemical_list: D007518:Isoantibodies; D014612:Vaccines